Onkologie. 2012:6(1):12-17
Treatment of neuropathic pain
- Nemocnice Atlas a.s., Zlín
The effective management of chronic pain is a fundamental goal for all clinicians and algesiologists. Neuropathic pain is one of two basic
kinds of pain, which appears either separetly or in combination with nociceptic pain. Neuropathic pain is very often treated by group
of specialist, who use farmatological procesess in combination with invazive and surgical technigues. The three-step analgesic ladder
developed by the Health Organisation (WHO) outlines these opioids in the management of cancer pain, and the application of opioid
therapy for the treatment of neuropathic pain. The author focuses on treatment of neuropathic pain, the use different opioid therapy.
She emphasized the preference of using oxycodone in the treatment of neuropathic pain and points to the good analgesic efficacy when
using low dosis of oxycodon and gabapentin. The author point out the basic kinds of koanalgetics, which are very important treatment
in neuropatic pain. At the endauthor concludes the article with two causes of oncologic patients describing solution the treatment of
neuropathic pain.
Keywords: neuropathic pain, opioids drugs, koanalgethics, gabapentin, oxycodon
Published: February 29, 2012 Show citation
References
- Rokyta R, Kršiak M, Kozák J. Bolest 2006: 227-244.
- Colombo B, Annovazzi PO, Comi G. Medication for neuropathic pain: Current trends. Neurol Sci 2006; (Suppl. 2): 183-189.
Go to original source... 
Go to PubMed... - Eissenberg E, Mc Nicol ED, Car DB. Efficacy of mi-opioid agonists in treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur J Pain 2006; 10: 667-676. Go to original source... Go to PubMed...
- Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118(3): 289-305. Go to original source... Go to PubMed...
- Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-34. Go to original source... Go to PubMed...
- Hanna M, et al. 5th Congres of the European Federation of IASP chapter (EFIC). 2006. Istanbul.
- Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372-80. Go to original source... Go to PubMed...
- Attal N, Cruccu G, Haanpaa M, Hansson Jensen TS, Nurmikko T, Sampatio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropatic pain. Eur J Neurol 2006; 13: 1153-1169. Go to original source... Go to PubMed...
- Riviere PJ. Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol 2004; 141: 1331-1334. Go to original source... Go to PubMed...
- Staahl C, Dimcevski AM, Anderson SD, et al. A comparative study of oxycodone and morphine in multimodal.tissue differented experimental pain model. Pain 2006; 123: 28-36. Go to original source... Go to PubMed...
- Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348(13): 1223-1232. Go to original source... Go to PubMed...
- Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: randomized controlled triat in painful diabetic neuropathy. Pain 2003; 105: 71-78. Go to original source... Go to PubMed...